Reference:WMA Declaration of Helsinki 2024 Paragraph 17 - Revision history

Gxplex admin: 1 revision imported

2026-07-16T11:50:07Z

1 revision imported

← Older revision	Revision as of 13:50, 16 July 2026
(No difference)

GxPlexBot: Migrate to Template:ReferenceData for PageForms (GxPlexBot)

2026-07-16T10:55:55Z

Migrate to Template:ReferenceData for PageForms (GxPlexBot)

← Older revision		Revision as of 12:55, 16 July 2026
Line 1:		Line 1:
	{{~~#set:~~		{{ReferenceData
	\|~~HasDocument~~=Document:WMA Declaration of Helsinki 2024		\|has_document=Document:WMA Declaration of Helsinki 2024
	\|~~RefScope~~=G		\|module=4
	\|~~RefDocPart~~=Paragraph 17		\|unit=4.2.1
	\|~~RefLanguage~~=EN		\|scope=G
	\|~~RefTags~~=TAG-00176-Ris-erh ++ TAG-00051-Eth-ngs ++ TAG-00177-Ben-koB ++ TAG-00025-Sub-mer		\|doc_part=Paragraph 17
	\|~~RefModule~~=4		\|language=EN
	~~\|RefUnit=4.2.1~~		\|entry_by=Florian Adragna
	}}		\|contributors=
			\|tags=TAG-00176-Ris-erh ++ TAG-00051-Eth-ngs ++ TAG-00177-Ben-koB ++ TAG-00025-Sub-mer
	~~{{:Document:WMA Declaration of Helsinki 2024}}~~		\|tags_display=[[Glossary:TAG-00176-Ris-erh\|Risk]], [[Glossary:TAG-00051-Eth-ngs\|Ethics]], [[Glossary:TAG-00177-Ben-koB\|Benefit-risk]], [[Glossary:TAG-00025-Sub-mer\|Trial participant]]
			\|comment=Careful risk assessment required before human research
	~~{\| class="wikitable gplx-infobox"~~		\|content=17. All medical research involving human participants must be preceded by careful assessment of predictable risks and burdens to the individuals and groups involved in the research in comparison with foreseeable benefits to them and to other individuals or groups affected by the condition under investigation.
	\|-
	~~! colspan="2" class="gplx-infobox-header" \| Reference Details~~
	\|-
	~~! Module~~
	~~\| Module 4 — Unit 4.2.1~~
	\|-
	~~! Scope~~
	~~\| G~~
	\|-
	~~! Document part~~
	~~\| Paragraph 17~~
	\|-
	~~! Language~~
	~~\| EN~~
	\|-
	~~! Original entry by~~
	~~\| Florian Adragna~~
	\|-
	~~! Contributors~~
	\|
	\|-
	~~! Tags~~
	\| [[Glossary:TAG-00176-Ris-erh\|Risk]], [[Glossary:TAG-00051-Eth-ngs\|Ethics]], [[Glossary:TAG-00177-Ben-koB\|Benefit-risk]], [[Glossary:TAG-00025-Sub-mer\|Trial participant]]
	\|-
	~~! Comment~~
	\| Careful risk assessment required before human research
	\|}

	=~~= Content ==~~
	17. All medical research involving human participants must be preceded by careful assessment of predictable risks and burdens to the individuals and groups involved in the research in comparison with foreseeable benefits to them and to other individuals or groups affected by the condition under investigation.

	Measures to minimize the risks and burdens must be implemented. The risks and burdens must be continuously monitored, assessed, and documented by the researcher.		Measures to minimize the risks and burdens must be implemented. The risks and burdens must be continuously monitored, assessed, and documented by the researcher.
			}}

gxplex>GxPlexBot: Import from GxPlex Excel

2026-07-15T15:29:01Z

Import from GxPlex Excel

← Older revision	Revision as of 17:29, 15 July 2026
(No difference)

imported>GxPlexBot: Import from GxPlex Excel

2026-07-15T15:29:01Z

Import from GxPlex Excel

← Older revision		Revision as of 17:29, 15 July 2026
Line 4:		Line 4:
	\|RefDocPart=Paragraph 17		\|RefDocPart=Paragraph 17
	\|RefLanguage=EN		\|RefLanguage=EN
	\|~~RefTagsEN~~=		\|RefTags=TAG-00176-Ris-erh ++ TAG-00051-Eth-ngs ++ TAG-00177-Ben-koB ++ TAG-00025-Sub-mer
	\|~~RefTagsOriginal~~=		\|RefModule=4
	\|~~RefTagsFR~~=		\|RefUnit=4.2.1
	}}		}}

Line 14:		Line 14:
	\|-		\|-
	! colspan="2" class="gplx-infobox-header" \| Reference Details		! colspan="2" class="gplx-infobox-header" \| Reference Details
			\|-
			! Module
			\| Module 4 — Unit 4.2.1
	\|-		\|-
	! Scope		! Scope
Line 30:		Line 33:
	\|		\|
	\|-		\|-
	! Tags ~~(EN)~~		! Tags
	\|		\| [[Glossary:TAG-00176-Ris-erh\|Risk]], [[Glossary:TAG-00051-Eth-ngs\|Ethics]], [[Glossary:TAG-00177-Ben-koB\|Benefit-risk]], [[Glossary:TAG-00025-Sub-mer\|Trial participant]]
	\|-
	~~! Tags (original language)~~
	\|
	\|-
	~~! Tags (FR)~~
	\|
	\|-		\|-
	! Comment		! Comment

Gxplex admin: 1 revision imported

2026-06-29T13:28:56Z

1 revision imported

← Older revision	Revision as of 15:28, 29 June 2026
(No difference)

gxplex>GxPlexBot: Import from GxPlex Excel

2026-06-29T13:27:17Z

Import from GxPlex Excel

← Older revision		Revision as of 15:27, 29 June 2026
Line 11:		Line 11:
	{{:Document:WMA Declaration of Helsinki 2024}}		{{:Document:WMA Declaration of Helsinki 2024}}

	{\| class="gplx-infobox"		{\| class="wikitable gplx-infobox"
	\|-		\|-
	! colspan="2" class="gplx-infobox-header" \| Reference Details		! colspan="2" class="gplx-infobox-header" \| Reference Details

Gxplex admin: 1 revision imported

2026-06-29T13:08:04Z

1 revision imported

← Older revision	Revision as of 15:08, 29 June 2026
(No difference)

gxplex>GxPlexBot: Import from GxPlex Excel

2026-06-29T13:06:54Z

Import from GxPlex Excel

← Older revision	Revision as of 15:06, 29 June 2026
(No difference)

Gxplex admin: 1 revision imported

2026-06-29T12:52:01Z

1 revision imported

← Older revision	Revision as of 14:52, 29 June 2026
(No difference)

gxplex>GxPlexBot: Import from GxPlex Excel

2026-06-29T12:27:21Z

Import from GxPlex Excel

← Older revision		Revision as of 14:27, 29 June 2026
Line 9:		Line 9:
	}}		}}

	~~== Document Information ==~~
	{{:Document:WMA Declaration of Helsinki 2024}}		{{:Document:WMA Declaration of Helsinki 2024}}

	~~== Reference Details ==~~		{\| class="gplx-infobox"
	{\| class="~~wikitable" style="width:100%;~~"
	\|-		\|-
	! ~~scope~~="~~row~~" ~~style~~="~~width:200px;~~" \| Scope		! colspan="2" class="gplx-infobox-header" \| Reference Details
			\|-
			! Scope
	\| G		\| G
	\|-		\|-
	! ~~scope="row" style="width:200px;" \|~~ Document part		! Document part
	\| Paragraph 17		\| Paragraph 17
	\|-		\|-
	! ~~scope="row" style="width:200px;" \|~~ Language		! Language
	\| EN		\| EN
	\|-		\|-
	! ~~scope="row" style="width:200px;" \|~~ Original entry by		! Original entry by
	\| Florian Adragna		\| Florian Adragna
	\|-		\|-
	! ~~scope="row" style="width:200px;" \|~~ Contributors		! Contributors
	\|		\|
	\|-		\|-
	! ~~scope="row" style="width:200px;" \|~~ Tags (EN)		! Tags (EN)
	\|		\|
	\|-		\|-
	! ~~scope="row" style="width:200px;" \|~~ Tags (original language)		! Tags (original language)
	\|		\|
	\|-		\|-
	! ~~scope="row" style="width:200px;" \|~~ Tags (FR)		! Tags (FR)
	\|		\|
	\|-		\|-
	! ~~scope="row" \|~~ Comment		! Comment
	\| Careful risk assessment required before human research		\| Careful risk assessment required before human research
	\|}		\|}

	== ~~Text~~ ==		== Content ==
	17. All medical research involving human participants must be preceded by careful assessment of predictable risks and burdens to the individuals and groups involved in the research in comparison with foreseeable benefits to them and to other individuals or groups affected by the condition under investigation.		17. All medical research involving human participants must be preceded by careful assessment of predictable risks and burdens to the individuals and groups involved in the research in comparison with foreseeable benefits to them and to other individuals or groups affected by the condition under investigation.

	Measures to minimize the risks and burdens must be implemented. The risks and burdens must be continuously monitored, assessed, and documented by the researcher.		Measures to minimize the risks and burdens must be implemented. The risks and burdens must be continuously monitored, assessed, and documented by the researcher.